Table 4.
The analysis of the markers of severity for COVID-19 patients with different ACE gene allelic variants.
| ACE gene polymorphism | P value | |||
|---|---|---|---|---|
| D/D | D/I | I/I | ||
| Agea (years) | 63 (48–66) | 69 (56–71) | 66 (46–68) | 0.232 |
| Lymphocytic countb (μl) | 0.88 ± 0.36α | 1.25 ± 0.38β | 1.8 ± 0.34μ | <0.001 ∗ |
| CRPa (mg/L) | 63α (36–81) | 33β (22–42) | 24β (23–31) | 0.001 ∗ |
| D-dimera (mg/L) | 0.79 (40–1.18) | 0.52 (37–89) | 0.78 (29–2.14) | 0.417 |
| Oxygen saturationb (%) | 77.8 ± 10.2α | 85.5 ± 8.1β | 84.8 ± 5.1β | 0.028 ∗ |
∗ Statistically significant results. aData were expressed as median and IQ. bData were expressed mean ± SD. Significant difference between α and β. Significant difference between α and μ. Significant difference between β and μ.